AstraZeneca

In News

AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment - Reuters

Reuters - Dec 15, 2025

Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million - Yahoo Finance

Yahoo Finance - Dec 17, 2025

AstraZeneca, Daiichi Sankyo Move Enhertu to First-Line Metastatic Breast Cancer - BioSpace

BioSpace - Dec 16, 2025

Salesforce supplies agentic AI platform to AstraZeneca for global HCP management - CHOSUNBIZ - Chosunbiz

Chosunbiz - Dec 18, 2025

Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards - USA Today

USA Today - Dec 17, 2025

AZ, Daiichi score with FDA nod for Enhertu combo in 1st-line breast cancer - Fierce Pharma

Fierce Pharma - Dec 15, 2025

Compugen rises on royalty deal with AstraZeneca (CGEN:NASDAQ) - Seeking Alpha

Seeking Alpha - Dec 17, 2025

AstraZeneca, Daiichi Sankyo ADC Enhertu Moves Up to First-Line Use in Breast Cancer - MedCity News

MedCity News - Dec 16, 2025

Cancer immunotherapy royalty deal brings biotech up to $90M in funding - Stock Titan

Stock Titan - Dec 17, 2025

Compugen Secures $90 Million in a Strategic Royalty Monetization Deal with AstraZeneca - TipRanks

TipRanks - Dec 17, 2025

University announces new partnership with AstraZeneca and Beijing municipal parties to accelerate innovations in healthcare - University of Cambridge

University of Cambridge - Dec 17, 2025

AstraZeneca’s Enhertu combination approved by FDA for HER2-positive breast cancer - PMLiVE

PMLiVE - Dec 17, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment